Security
Smith & Nephew plc · SNN
SNNNYSECommon stockCurrentCIK 845982Updated Nov 3, 2026
SNN price & chart
Loading TradingView…
NYSE:SNN on TradingView ↗In the news
Recent filings
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Profit or LossUSD | 625,000,000Source | 412,000,000Source | 263,000,000Source | 223,000,000Source |
| Cash flows from financing activities: | ||||
| Dividends paid | —Source | —Source | —Source | —Source |
| Additional Financial Items | ||||
| AdjustmentsForCurrentTaxOfPriorPeriodUSD | -41,000,000Source | -37,000,000Source | -45,000,000Source | -10,000,000Source |
| AdjustmentsForDeferredTaxOfPriorPeriodsUSD | 16,000,000Source | 7,000,000Source | 10,000,000Source | -17,000,000Source |
| AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossUSD | 573,000,000Source | 645,000,000Source | 683,000,000Source | 617,000,000Source |
| AdjustmentsForSharebasedPaymentsUSD | 43,000,000Source | 40,000,000Source | 39,000,000Source | 40,000,000Source |
| AdjustmentsForUndistributedProfitsOfAssociatesUSD | 113,000,000Source | -10,000,000Source | -30,000,000Source | -141,000,000Source |
| DividendsProposedOrDeclaredBeforeFinancialStatementsAuthorisedForIssueButNotRecognisedAsDistributionToOwnersUSD | 204,000,000Source | — | — | — |
| GoodwillUSD | 3,108,000,000Source | 3,026,000,000Source | 2,992,000,000Source | 3,031,000,000Source |
| InterestPaidClassifiedAsOperatingActivitiesUSD | 142,000,000Source | 140,000,000Source | 104,000,000Source | 73,000,000Source |
| InterestReceivedClassifiedAsOperatingActivitiesUSD | 25,000,000Source | 22,000,000Source | 8,000,000Source | 7,000,000Source |
| PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivitiesUSD | 50,000,000Source | 55,000,000Source | 52,000,000Source | 54,000,000Source |
| PaymentsToAcquireOrRedeemEntitysSharesUSD | 502,000,000Source | — | — | 158,000,000Source |
| ProceedsFromBorrowingsClassifiedAsFinancingActivitiesUSD | 43,000,000Source | — | 326,000,000Source | — |
| ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivitiesUSD | 38,000,000Source | — | — | — |
| PurchaseOfFinancialAssetsMeasuredAtFairValueThroughProfitOrLossClassifiedAsInvestingActivitiesUSD | 2,000,000Source | 1,000,000Source | — | — |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cost of Goods and Services Sold | —Source | —Source | —Source | —Source |
| Selling, General and Administrative ExpenseUSD | 3,102,000,000Source | 3,100,000,000Source | 3,055,000,000Source | 2,880,000,000Source |
| Total Revenue | — | — | — | — |
| Additional Financial Items | ||||
| AdministrativeExpenseUSD | 740,000,000Source | 824,000,000Source | 837,000,000Source | 814,000,000Source |
| ApplicableTaxRatenumber | 0.25Source | 0.25Source | 0.24Source | 0.19Source |
| BasicEarningsLossPerShareUSD per share | 0.72Source | 0.47Source | 0.3Source | 0.26Source |
| CurrentTaxExpenseIncomeUSD | 170,000,000Source | 195,000,000Source | 180,000,000Source | 121,000,000Source |
| DeferredTaxExpenseIncomeUSD | — | — | — | -99,000,000Source |
| DeferredTaxExpenseIncomeRecognisedInProfitOrLossUSD | 25,000,000Source | -72,000,000Source | -108,000,000Source | -77,000,000Source |
| DepreciationAmortisationAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossUSD | — | — | 207,000,000Source | 205,000,000Source |
| DepreciationPropertyPlantAndEquipmentIncludingRightofuseAssetsUSD | 335,000,000Source | 325,000,000Source | — | — |
| DepreciationRightofuseAssetsUSD | 49,000,000Source | 54,000,000Source | 54,000,000Source | 56,000,000Source |
| DilutedEarningsLossPerShareUSD per share | 0.72Source | 0.47Source | 0.3Source | 0.26Source |
| EmployeeBenefitsExpenseUSD | 2,063,000,000Source | 2,042,000,000Source | 2,059,000,000Source | 1,908,000,000Source |
| ExpenseFromSharebasedPaymentTransactionsWithEmployeesUSD | 43,000,000Source | 40,000,000Source | 39,000,000Source | 40,000,000Source |
| FinanceIncomeUSD | 28,000,000Source | 24,000,000Source | 34,000,000Source | 14,000,000Source |
| GrossProfitUSD | 4,192,000,000Source | 4,046,000,000Source | 3,819,000,000Source | 3,675,000,000Source |
| ImpairmentLossRecognisedInProfitOrLossGoodwillUSD | 0Source | 65,000,000Source | 84,000,000Source | — |
| ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwillUSD | 10,000,000Source | 16,000,000Source | 37,000,000Source | — |
| ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipmentIncludingRightofuseAssetsUSD | — | 9,000,000Source | — | — |
| IncomeTaxExpenseContinuingOperationsUSD | 154,000,000Source | 86,000,000Source | 27,000,000Source | 12,000,000Source |
| InterestExpenseUSD | 140,000,000Source | 145,000,000Source | 132,000,000Source | 80,000,000Source |
| InterestExpenseOnLeaseLiabilitiesUSD | 8,000,000Source | 8,000,000Source | 8,000,000Source | 6,000,000Source |
| OtherFinanceCostUSD | 16,000,000Source | 28,000,000Source | 7,000,000Source | 8,000,000Source |
| OtherOperatingIncomeExpenseUSD | — | — | 0Source | 7,000,000Source |
| PostemploymentBenefitExpenseDefinedBenefitPlansUSD | 13,000,000Source | 6,000,000Source | 11,000,000Source | 11,000,000Source |
| PostemploymentBenefitExpenseDefinedContributionPlansUSD | 81,000,000Source | 89,000,000Source | 84,000,000Source | 77,000,000Source |
| ProfitLossBeforeTaxUSD | 779,000,000Source | 498,000,000Source | 290,000,000Source | 235,000,000Source |
| ProfitLossFromOperatingActivitiesUSD | 794,000,000Source | 657,000,000Source | 425,000,000Source | 450,000,000Source |
| ResearchAndDevelopmentExpenseUSD | 296,000,000Source | 289,000,000Source | 339,000,000Source | 345,000,000Source |
| ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethodUSD | — | — | — | -32,000,000Source |
Filing attachments
snn-20260331xex99d1.htm · 6-K · 2026-03-16
Exhibit 99.1 Life Unlimited Annual Report 2025 1 These non-IFRS financial measures are explained and reconciled to the most directly comparable financial measure prepared in accordance with IFRS on pages 285–292. The images used throughout the report represent the ways that Smith+Nephew is taking the limits off living and helping patients live Life Unlimited. Images used are not photographs of our patients unless expressly indicated. Performance Group revenue Operating profit T…
Read attachment ↗